Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized placebo-controlled trial which aims to evaluate the
efficacy and safety of Wen Xin granule in patients with unstable angina pectoris.
Phase:
Phase 4
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Collaborators:
National Natural Science Foundation of China Special Project of National Traditional Chinese Medicine Clinical Research Base of State Administration of Traditional Chinese Medicine